Analysis | GPI | Standard treatment | MD | 95% CI | P value | I2 (%) |
Age | 66.6 ± 12.6 | 69.1 ± 12.3 | − 2.75 | − 0.64 to 0.83 | 0.13 | 74 |
LVEF | 35 ± 9 | 32 ± 10 | 0.33 | − 1.83 to 2.49 | 0.63 | 27 |
Analysis | GPI | Standard treatment | OR | 95% CI | P value | I2 (%) |
Gender (male)* | 470/640 | 258/397 | 1.43 | 1.09–1.89 | 0.01 | 8 |
Diabetes mellitus | 112/470 | 90/306 | 0.77 | 0.55–1.08 | 0.13 | 0 |
Hypertension* | 247/425 | 168/225 | 0.68 | 0.49–0.94 | 0.02 | 74 |
Tobacco use* | 197/470 | 87/306 | 1.87 | 1.20–2.91 | 0.006 | 36 |
Previous MI | 82/470 | 77/306 | 0.75 | 0.48–1.18 | 0.21 | 25 |
3 vessel disease | 181/425 | 124/225 | 0.64 | 0.29–1.45 | 0.29 | 79 |
Left main lesion | 74/446 | 31/298 | 1.54 | 0.52–4.57 | 0.44 | 76 |
Invasive ventilation | 312/586 | 198/338 | 1.20 | 0.62–2.23 | 0.57 | 65 |
IABP | 363/640 | 149/397 | 2.13 | 0.96–4.72 | 0.06 | 82 |
TIMI 0/1 pre-procedure | 167/595 | 185/346 | 0.60 | 0.19–1.88 | 0.38 | 90 |